Ceftin (Cefuroxime Axetil) Oral Suspension
Company:  Glaxo Wellcome, Inc.
Application No.:  50672/S014
Approval Date: 8/24/1999

• Approval Letter(s) & Medical Review(s) (1.4 MB)

• Chemistry Review(s), Clinical Pharmacology Biopharmaceutics Review(s), & Administrative Document(s)/Correspondence (2.4 MB)

Back to Top     Back to Drugs@FDA

PDF requires the free Adobe Acrobat Reader

Date created: March 30, 2001

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research